Skip to main content
SpringerLink
Log in

Cost-Benefit Analysis of Vaccination Against Influenza of Employees from an Academic Medical Centre

  • Original Research Article
  • Published:
Disease Management & Health Outcomes

Abstract

Objective: To determine whether vaccination against influenza in the Academic Medical Centre (AMC) of the University of Amsterdam, The Netherlands, may lead to an economic benefit by avoiding the loss in productivity associated with an outbreak of influenza illness among its employees.

Design: A newly developed cost-benefit model from an employer’s perspective was applied and several scenario and sensitivity analyses were performed.

Methods: The model inputs were vaccination-, personnel- and influenza-related elements, which were obtained from data specific to the AMC where possible, otherwise these were based on published literature. The output (net benefit) was defined as the difference between the benefits of vaccination due to reducing workplace absenteeism (productivity) of employees and the costs of vaccination, excluding campaign and administration costs. The net benefits of baseline, vaccination promotion and influenza-persistent scenarios were assessed and sensitivity analysis was performed.

Results: The net benefits for all the scenarios was positive, being 120 000 Euros (EUR), EUR460 000 and EUR180 000 (2000 values) for the baseline, vaccination promotion and influenza-persistent scenarios, respectively. The vaccination compliance rate appeared to be the element with greatest impact on the net benefits.

Conclusion: An influenza vaccination program in an institution with the characteristics of the AMC can be performed with an economic benefit for the organization. Our results suggest that vaccination of medical residents provides greater economic benefits than vaccination of other personnel.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Table II
Fig. 2
Table III

Similar content being viewed by others

References

  1. Szucs TD. Influenza the role of burden-of-illness research. Pharmacoeconomics 1999; 16: 27–32.

    Article  PubMed  Google Scholar 

  2. Wood SZ, Nguyen HV, Schmidt C. Economic evaluations of influenza vaccination in healthy working-adults. Pharmacoeconomics 2000; 18: 173–83.

    Article  PubMed  CAS  Google Scholar 

  3. Schoenbaum SC. Economic impact of influenza: the individual’s perspective. Am J Med 1987; 295: 759–65.

    Google Scholar 

  4. Riddiough MA, Sisk JE, Bell JC. Influenza vaccination: cost-effectiveness and public policy. JAMA 1983; 249: 3189–95.

    Article  PubMed  CAS  Google Scholar 

  5. Weingarten S, Staniloff H, Ault M, et al. Do hospital employees benefit from the influenza vaccine: a placebo-controlled clinical trial. J Gen Intern Med 1988; 3: 32–7.

    Article  PubMed  CAS  Google Scholar 

  6. Pachucki CT, Lentino JR, Jackson GG. Attitudes and behaviour of health care personnel regarding the use and efficacy of influenza vaccine. J Infect Dis 1985; 151: 1170–1.

    Article  PubMed  CAS  Google Scholar 

  7. Cram P, Blitz SG, Monto A, et al. Influenza: cost of illness and considerations in the economic evaluation of new and emerging therapies. Pharmacoeconomics 2001; 19: 223–30.

    Article  PubMed  CAS  Google Scholar 

  8. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995; 333: 889–93.

    Article  PubMed  CAS  Google Scholar 

  9. Burckel E, Ashraf T, de Sousa Filho JPG, et al. Economic impact of providing workplace influenza vaccination. Pharmacoeconomics 1999; 16: 563–76.

    Article  PubMed  CAS  Google Scholar 

  10. Reinders A, Postma MJ, Govaert TM, et al. Cost-effectiveness of influenza vaccination in The Netherlands [in Dutch]. Ned Tijdschr Geneeskd 1997; 141: 93–7.

    PubMed  CAS  Google Scholar 

  11. Turban E. Decision support and expert systems: management support systems. 2nd ed. New York (NY): Macmillan Publishing Company, 1990.

    Google Scholar 

  12. Watanakunakorn C, Ellis G, Gemmel D. Attitude of healthcare personnel regarding influenza immunization. Infect Control Hosp Epidemiol 1993; 14: 17–20.

    Article  PubMed  CAS  Google Scholar 

  13. Heimberger T, Chang HG, Shaikh M, et al. Knowledge and attitudes of healthcare workers about influenza: why are they not getting vaccinated. Infect Control Hosp Epidemiol 1995; 16: 412–25.

    Article  PubMed  CAS  Google Scholar 

  14. Yassi A, Kettner J, Hammond G, et al. Effectiveness and cost-benefit of an influenza vaccination program for healthcare workers. Can J Infect Dis 1991; 2: 101–8.

    PubMed  CAS  Google Scholar 

  15. Department of Internal and External Communications. Annual Report 2000. Amsterdam: Department of Internal and External Communications, AMC, 2000.

  16. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of healthcare workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997; 175: 1–6.

    Article  PubMed  CAS  Google Scholar 

  17. Carmen WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of healthcare workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000; 355: 93–7.

    Article  Google Scholar 

  18. Sprenger MJ, Diepersloot RJ, Beyer WE, et al. Influenza related excess mortality in The Netherlands 1989/1990. Lancet 1990; 11: 336–82.

    Google Scholar 

  19. Jefferson T, Mugford M, Gray A, et al. An exercise on the feasibility of carrying out secondary economic analyses. Health Econ 1996; 5: 155–65.

    Article  PubMed  CAS  Google Scholar 

  20. Nichol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778–84.

    Article  PubMed  CAS  Google Scholar 

  21. Nichol KL, Margolis KL, Lind A, et al. Side effects associated with influenza vaccination in healthy working adults: a randomised placebo-controlled trial. Arch Intern Med 1996; 156: 1546–50.

    Article  PubMed  CAS  Google Scholar 

  22. Campbell DS, Rumley MH. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occup Environ Med 1997; 39: 408–14.

    Article  PubMed  CAS  Google Scholar 

  23. Kumpulainen V, Makela M. Influenza vaccination among healthy employees: a cost-benefit analysis. Scand J Infect Dis 1997; 29: 181–5.

    Article  PubMed  CAS  Google Scholar 

  24. Levy E, Levy P. La vaccination contre la grippe des personnes d’age actif (24–64 ans): une étude coût bénéfice. Rev Epidemiol Sante Publique 1992; 10: 285–95.

    Google Scholar 

  25. Nichol KL. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 2001; 161: 749–59.

    Article  PubMed  CAS  Google Scholar 

  26. Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 1988; 127: 353–64.

    PubMed  CAS  Google Scholar 

  27. Glezen WP, Falcao O, Cate TR, et al. Nosocomial influenza in a general hospital for indigent patients. Can J Infect Control 1991; 6: 65–7.

    PubMed  CAS  Google Scholar 

  28. Saxen H, Virtanen M. Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers. Pediatr Infect Dis J 1999; 18: 779–83.

    Article  PubMed  CAS  Google Scholar 

  29. Wilde JA, McMillan JA Serwint J, et al. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 1999; 281: 908–13.

    Article  PubMed  CAS  Google Scholar 

  30. Olsen GW, Burris JM, Burlew MM, et al. Absenteeism among employees who participated in a workplace influenza immunization program. J Occup Environ Med 1998; 40: 311–6.

    Article  PubMed  CAS  Google Scholar 

  31. Nichol KL, Mendelman PM, Mallon KP, et al. Effectiveness of live, attenuated intranasal influenza virus in healthy, working adults: a randomized controlled trial. JAMA 1999; 282: 137–44.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this manuscript. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacy, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands

    Wilma Parlevliet (clinical epidemiologist) & Henk-Jan Guchelaar

  2. Department of Clinical Epidemiology and Biostatistics, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands

    Corianne de Borgie (physician occupational medicine)

  3. Department of Business Health Service, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands

    Gerard Frijstein (clinical pharmacist)

Authors
  1. Wilma Parlevliet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Corianne de Borgie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerard Frijstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Henk-Jan Guchelaar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Henk-Jan Guchelaar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parlevliet, W., de Borgie, C., Frijstein, G. et al. Cost-Benefit Analysis of Vaccination Against Influenza of Employees from an Academic Medical Centre. Dis-Manage-Health-Outcomes 10, 579–587 (2002). https://doi.org/10.2165/00115677-200210090-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200210090-00006

Keywords

Search

Navigation